Skip to main content

News

Press Release
09/11/2019
Patients who live in rural areas are in need of access to proper and convenient care. According to a 2018 study, over 85.5 million people in rural areas need better access to healthcare — this translates to a need of 4,022...
Patients who live in rural areas are in need of access to proper and convenient care. According to a 2018 study, over 85.5 million people in rural areas need better access to healthcare — this translates to a need of 4,022...
Patients who live in rural areas...
09/11/2019
EP Lab Digest
Press Release
09/06/2019
The OrthoVest is a personal protective device in use at several facilities and is currently undergoing testing in the cardiac electrophysiology (EP) lab at the University of Chicago and in the cardiac catheterization lab at Keele University...
The OrthoVest is a personal protective device in use at several facilities and is currently undergoing testing in the cardiac electrophysiology (EP) lab at the University of Chicago and in the cardiac catheterization lab at Keele University...
The OrthoVest is a personal...
09/06/2019
EP Lab Digest
Press Release
09/06/2019
BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, announced that its subsidiary,...
BioSig Technologies, Inc., a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, announced that its subsidiary,...
BioSig Technologies, Inc., a...
09/06/2019
EP Lab Digest
Press Release
09/06/2019
iRhythm Technologies, Inc. announced a collaboration with Verily, an Alphabet company, focused on the development of solutions aimed at improving the screening, diagnosis and management of patients with atrial fibrillation (AFib). This...
iRhythm Technologies, Inc. announced a collaboration with Verily, an Alphabet company, focused on the development of solutions aimed at improving the screening, diagnosis and management of patients with atrial fibrillation (AFib). This...
iRhythm Technologies, Inc....
09/06/2019
EP Lab Digest
Press Release
09/06/2019
Orchestra BioMed™, Inc., a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, announced that it has received CE Mark approval for its Moderato® implantable pulse generator system...
Orchestra BioMed™, Inc., a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, announced that it has received CE Mark approval for its Moderato® implantable pulse generator system...
Orchestra BioMed™, Inc., a...
09/06/2019
EP Lab Digest
Press Release
09/06/2019
Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the 14-Day version of...
Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the 14-Day version of...
Bardy Diagnostics, Inc., a...
09/06/2019
EP Lab Digest
Press Release
09/04/2019
AtriCure, Inc., a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of additional...
AtriCure, Inc., a leading innovator in surgical treatment for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of additional...
AtriCure, Inc., a leading...
09/04/2019
EP Lab Digest
Press Release
09/04/2019
Paris, France – 3 Sept 2019: Edoxaban in combination with a P2Y12 inhibitor is noninferior to standard triple therapy for preventing bleeding in patients with atrial fibrillation after coronary stenting. The late breaking results of the...
Paris, France – 3 Sept 2019: Edoxaban in combination with a P2Y12 inhibitor is noninferior to standard triple therapy for preventing bleeding in patients with atrial fibrillation after coronary stenting. The late breaking results of the...
Paris, France – 3 Sept 2019:...
09/04/2019
EP Lab Digest
Press Release
09/03/2019
Paris, France – 3 Sept 2019: Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line Session...
Paris, France – 3 Sept 2019: Implantable cardioverter-defibrillator (ICD) use is associated with reduced short- and long-term mortality in patients with heart failure, according to late breaking research presented in a Hot Line Session...
Paris, France – 3 Sept 2019:...
09/03/2019
EP Lab Digest
Press Release
09/03/2019
The European Society of Cardiology (ESC) Guidelines on supraventricular tachycardia were published online in European Heart Journal,(1) and on the ESC website.(2) The document highlights how catheter ablation is revolutionizing care for...
The European Society of Cardiology (ESC) Guidelines on supraventricular tachycardia were published online in European Heart Journal,(1) and on the ESC website.(2) The document highlights how catheter ablation is revolutionizing care for...
The European Society of...
09/03/2019
EP Lab Digest